Premier Biomedical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019
Premier Biomedical, Inc. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was USD 14,281 compared to USD 39,795 a year ago. Operating loss was USD 326,735 compared to USD 692,842 a year ago. Net loss was USD 374,470 compared to USD 398,886 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.11 a year ago.